Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancerAnderson J. Ryan, Judith H. Harmey|British Journal of Cancer|2009Cited by 65
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Gareth L. Bond, Siddhartha Kar et al.|Cancer Research|2021Cited by 49
Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient MiceSeiji Yano, Saburo Sone, Hiroaki Muguruma et al.|Clinical Cancer Research|2005Cited by 48
Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cellsSivan Bokobza, Anderson J. Ryan|Oncotarget|2014Cited by 46
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard Walls, Alastair Greystoke, Jamie B. Oughton et al.|Clinical and Translational Radiation Oncology|2020Cited by 34